1 hour Continuing Professional Development: what you will learn
This crucial webinar is designed to enhance your knowledge for interpreting complicated Flash Glucose Monitoring data plus answer your questions on:
Designed to cement your learning and enhance your knowledge
Introduction, instructions and chair’s opening remarks
Ramzi Ajjan, Professor of Metabolic Medicine, University of Leeds
Higher data interpretation for Flash Glucose Monitoring
- Develop your skills for identifying behavioural and treatment patterns in your patients’ data
- Identifying and providing evidenced and considered guidance on nocturnal hypos
- Assessing and making timely clinical decisions from chaotic data
- Quickly and efficiently recognising dawn phenomenon, insulin stacking, postprandial glucose and high glucose in the morning
Emma Wilmot, Consultant Diabetologist, University Hospitals of Derby and Burton NHS Foundation Trust and Iain Cranston, Consultant Physician (Diabetes & Endocrinology), Portsmouth Hospitals NHS Trust
Questions and answers with the speakers
- Your webinar host and presenters will use this time to answer questions which have been asked throughout the presentations plus any discussion points to build your confidence for interpreting data.
Ramzi Ajjan, Professor of Metabolic Medicine, University of Leeds, Emma Wilmot, Consultant Diabetologist, University Hospitals of Derby and Burton NHS Foundation Trust and Iain Cranston, Consultant Physician (Diabetes & Endocrinology), Portsmouth Hospitals NHS Trust
First-hand speaker experience
Professor of Metabolic Medicine
University of Leeds
Professor Ajjan (MD, FRCP, MMed.Sci, PhD) obtained his PhD from the University of Sheffield and completed his clinical training in Diabetes and Endocrinology at Leeds Teaching Hospitals Trust. Professor Ajjan’s research work covers a spectrum of basic, translational and clinical studies with the common aim of reducing vascular complications in diabetes and reducing morbidity and mortality in this high-risk population. His research group described three novel mechanisms for hypofibrinolysis in diabetes, with both hypo and hyperglycaemia having key roles. Moreover, Professor Ajjan has shown a close relationship between hypoglycaemia and adverse clinical outcome in patients with diabetes.
Given the pathogenic effects of high and low blood glucose levels, he has been involved in a number of studies investigating the role of continuous glucose monitoring in optimising glycaemic control in diabetes. Professor Ajjan’s research work has been published in peer reviewed journals and he has over 100 publications including original papers, reviews and book chapters.
His clinical practice concentrates on complicated type 2 diabetes patients with established cardiovascular disease as well as young adults with diabetes. Professor Ajjan is the R&D lead for Diabetes/Endocrinology at Leeds Teaching Hospitals Trust and the regional clinical research network lead for endocrine and metabolic conditions. He is also the lead for first year medical student teaching in Endocrinology and Diabetes at Leeds University and co-lead of the Atherothrombosis and Diabetes group within Leeds Institute for Cardiovascular and Metabolic Medicine.
University Hospitals of Derby and Burton NHS Foundation Trust
Consultant Physician (Diabetes & Endocrinology)
Portsmouth Hospitals NHS Trust
Dr Iain Cranston is a diabetes physician based in Portsmouth, UK. He has specialty responsibility for the delivery of technology-driven services (CSII / CGM etc.) to approximately 1% of the UK population. Alongside this, he is the lead diabetes clinician for the Wessex renal and transplant centre, managing individuals with specific and high glycaemic risks. He has a background in clinical research, obtained during his time at Guy’s and King’s College and St Thomas’ Hospitals, into impaired awareness of hypoglycaemia in insulin-treated diabetes and the cerebral and endocrine mechanisms underlying the syndrome.
For the last 20 years, Dr Cranston has been in practice with the goal of translating the lessons learnt from research into routine clinical care consultations. This has resulted in a focus on effective glucose monitoring strategies to underpin clinical decision-making and the development of data analytical processes to guide clinical consultations towards more effective therapeutic interventions in both type 1 and type 2 diabetes. He has published widely on this topic area (over 60 Peer-reviewed publications) and has been an invited speaker at Diabetes UK, EASD and many National meetings around the world.
For the last 4 years, Dr Cranston has been a co-director in a collaborative educational project with Professor Roger Mazze (International Diabetes Center [IDC] Minnesota), at the AGP Clinical Academy, which has the central goal of educating healthcare professionals in the effective clinical interpretation of the ambulatory glucose profile derived from continuous glucose monitoring technologies.
Supporting NHS professionals during Covid-19